SCHEMBL4028015

SCHEMBL4028015

CC(=O)Nc1cc2onc(CCc3sc(-c4ccccc4C(F)(F)F)nc3C(C)C)c2cc1C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 5/20 0.54
PPARD Q03181 5/20 0.54
PPARA Q07869 5/20 0.54
KDM4E B2RXH2 2/20 0.34
TP53 P04637 2/20 0.33
HTT P42858 1/20 0.33
TSHR P16473 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
BCHE P06276 1/20 0.32
ACHE P22303 1/20 0.32
MCHR1 Q99705 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
DPP4 P27487 1/20 0.31
DPP7 Q9UHL4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4024977 0.89 PPARD (0.54) PPARGPPARDPPARATSHRCYP1A2
SCHEMBL4799615 0.88 PPARG (0.51) PPARGPPARDPPARAKDM4ESMN1; SMN2
SCHEMBL4028013 0.87 PPARD (0.71) PPARGPPARDPPARANPC1
SCHEMBL4033028 0.86 PPARG (0.54) PPARGPPARDPPARATSHRSMN1; SMN2
SCHEMBL4034567 0.84 PPARG (0.53) PPARGPPARDPPARATSHRCYP1A2
SCHEMBL4025440 0.83 PPARA (0.77) PPARGPPARDPPARAACHE
SCHEMBL3393036 0.83 PPARD (0.62) PPARGPPARDPPARACYP3A4KMT2A
SCHEMBL4026350 0.83 PPARD (0.54) PPARGPPARDPPARASMN1; SMN2ACHE
SCHEMBL4030150 0.82 PPARG (0.52) PPARGPPARDPPARATSHRCYP1A2
SCHEMBL4034202 0.82 PPARG (0.52) PPARGPPARDPPARAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1445258-B1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA NIPPON CHEMIPHAR CO (JP) 2009-06-24 EP disclosed
US-7402597-B2 Activator of peroxisome proliferator-activated receptor δ NIPPON CHEMIPHAR CO., LTD (JP) 2008-07-22 US disclosed
US-20070027196-A1 Activator of peroxisome proliferator-activated receptor delta SAKUMA SHOGO 2007-02-01 US disclosed
US-7119104-B2 Activator of peroxisome proliferator-activated receptor delta NIPPON CHEMIPHAR, CO., LTD. (JP) 2006-10-10 US disclosed
US-20050096363-A1 Activator of peroxisome proliferator-activated receptor delta NIPPON CHEMIPHAR CO., LTD. (JP) 2005-05-05 US disclosed
EP-1445258-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA NIPPON CHEMIPHAR CO., LTD. (JP) 2004-08-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027196-A1 Activator of peroxisome proliferator-activated receptor delta PPARA, PPARG, PPARD PPARG 2/4885PPARD 3/4885PPARA 1/4885
US-20050096363-A1 Activator of peroxisome proliferator-activated receptor delta PPARA, PPARG, PPARD PPARG 2/4885PPARD 3/4885PPARA 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.